- Report
- August 2024
- 200 Pages
Global
From €3709EUR$3,869USD£3,099GBP
- Report
- October 2023
- 173 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- February 2019
- 170 Pages
Global
From €5990EUR$6,693USD£5,180GBP
- Report
- November 2024
- 77 Pages
Global
From €3500EUR$3,911USD£3,027GBP
Nanopore sequencing is a type of DNA sequencing technology that uses nanopores to detect single molecules of DNA. It is used in nanomedicine to sequence and analyze genetic material, such as DNA and RNA, for diagnostic and therapeutic purposes. Nanopore sequencing is a cost-effective and rapid method for sequencing and analyzing genetic material, which can be used to identify genetic mutations, detect pathogens, and monitor gene expression. It can also be used to study the structure and function of proteins, and to develop personalized treatments for diseases.
Nanopore sequencing is becoming increasingly popular in the nanomedicine market, as it offers a number of advantages over traditional sequencing methods. It is faster, more accurate, and more cost-effective than other sequencing methods, and can be used to analyze large amounts of genetic material in a short period of time.
Some companies in the Nanopore sequencing market include Oxford Nanopore Technologies, Pacific Biosciences, Illumina, Thermo Fisher Scientific, and BGI. Show Less Read more